Atyr Pharma Inc (NASDAQ:ATYR) price on Thursday, March 20, fall -2.08% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.76.
A look at the stock’s price movement, the close in the last trading session was $3.84, moving within a range at $3.675 and $3.9. Turning to its 52-week performance, $4.66 and $1.42 were the 52-week high and 52-week low respectively. Overall, ATYR moved -11.53% over the past month.
Atyr Pharma Inc’s market cap currently stands at around $334.11 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-12.
The average forecast suggests down to a -100.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 2M, representing a 751.06% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ATYR is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
ATYR’s current price about 3.36% and 2.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 51.99, while 7-day volatility ratio is 9.41% and 11.22% in the 30-day chart. Further, Atyr Pharma Inc (ATYR) has a beta value of 0.86, and an average true range (ATR) of 0.37.
If we refocus on Atyr Pharma Inc (NASDAQ:ATYR), historical trading data shows that trading volumes averaged 1.93 over the past 10 days and 1.28 million over the past 3 months. The company’s latest data on shares outstanding shows there are 88.86 million shares.
The 3.22% of Atyr Pharma Inc’s shares are in the hands of company insiders while institutional holders own 62.69% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.26 million on 2025-02-28, giving us a short ratio of 4.17. The data shows that as of 2025-02-28 short interest in Atyr Pharma Inc (ATYR) stood at 823.99994 of shares outstanding, with shares short rising to 3.82 million registered in 2025-01-31. Current price change has pushed the stock 3.87% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ATYR stock continues to rise going into the next quarter.
